Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Muscarinic acetylcholine receptor M3 | ||
Ligand | BDBM50595416 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_2216667 (CHEMBL5129799) | ||
Ki | 3.2±n/a nM | ||
Citation | Carzaniga, L; Linney, ID; Rizzi, A; Delcanale, M; Schmidt, W; Knight, CK; Pastore, F; Miglietta, D; Carnini, C; Cesari, N; Riccardi, B; Mileo, V; Venturi, L; Moretti, E; Blackaby, WP; Patacchini, R; Accetta, A; Biagetti, M; Bassani, F; Tondelli, M; Murgo, A; Battipaglia, L; Villetti, G; Puccini, P; Catinella, S; Civelli, M; Rancati, F Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and ? J Med Chem65:10233-10250 (2022) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Muscarinic acetylcholine receptor M3 | |||
Name: | Muscarinic acetylcholine receptor M3 | ||
Synonyms: | ACM3_HUMAN | CHRM3 | Cholinergic, muscarinic M3 | Muscarinic Receptors M3 | Muscarinic receptor M3 | RecName: Full=Muscarinic acetylcholine receptor M3 | ||
Type: | Enzyme | ||
Mol. Mass.: | 66151.03 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P20309 | ||
Residue: | 590 | ||
Sequence: |
| ||
BDBM50595416 | |||
n/a | |||
Name | BDBM50595416 | ||
Synonyms: | CHEMBL5178217 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H30N4O5 | ||
Mol. Mass. | 490.5509 | ||
SMILES | Cn1nc(COc2cccc(c2)[C@@H](NC(=O)O[C@H]2CN3CCC2CC3)c2ccccc2)cc1C(O)=O |r,wU:12.13,wD:17.17,THB:16:17:20.21:23.24,(-9.99,.25,;-8.45,.25,;-7.42,1.4,;-6.01,.77,;-4.68,1.54,;-3.35,.77,;-2.01,1.54,;-2.01,3.08,;-.68,3.85,;.66,3.08,;.66,1.54,;-.68,.77,;1.99,.77,;3.32,1.54,;4.66,.77,;4.66,-.77,;5.99,1.54,;7.32,.77,;7.32,-.77,;8.66,-1.54,;7.95,-.31,;9.37,.31,;8.66,1.54,;9.99,.77,;9.99,-.77,;1.99,-.77,;3.32,-1.54,;3.32,-3.08,;1.99,-3.85,;.66,-3.08,;.66,-1.54,;-6.17,-.76,;-7.68,-1.08,;-8.31,-2.49,;-9.84,-2.65,;-7.4,-3.73,)| | ||
Structure |